Literature DB >> 3874074

Interleukin 2 induces T cell-dependent IgM production in human B cells.

R W Sauerwein, W G Van der Meer, A Dräger, L A Aarden.   

Abstract

Conditioned medium, obtained from mononuclear cells after activation with concanavalin A and phorbol myristate, strongly stimulated the in vitro production of IgM by human mononuclear cells. Partial purification by gel filtration showed that this activity co-eluted with interleukin 2 (IL 2). Via removal by adsorption and further purification by chromatofocusing techniques, it was demonstrated that the factor in this conditioned medium, responsible for the IgM production, was in fact IL 2. Experiments with purified IL 2 from the human IL 2-producing Jurkat cell line as well as recombinant IL 2 confirmed its capacity to induce IgM production. In the absence of T cells, IL 2 could not activate Ig synthesis, suggesting an indirect effect of IL 2 in the induction of the helper signals for B cells. Evidence is presented that partially purified conditioned medium contained another factor, distinct from IL 2, with the capacity to differentiate human B lymphocytes in the absence of T cells into IgM-producing cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874074     DOI: 10.1002/eji.1830150615

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Analysis of helper activity on pokeweed mitogen- and interleukin 2-driven immunoglobulin synthesis by neoplastic T4+ cells.

Authors:  F Miedema; J W van Oostveen; F G Terpstra; A W van den Wall Bake; R Willemze; E A Rauws; R Bieger; M B van 't Veer; D Catovsky; C J Melief
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

2.  T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2.

Authors:  A M Draeger; A J Swaak; H G van den Brink; L A Aarden
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.